Low-grade serous ovarian cancer (LGSOC), which predominantly affects women in their 20s and 30s, is rare and was only recognised as a distinct type of ovarian cancer in the past 15 years. Much remains unknown about LGSOC, and treatments for other types of ovarian cancer are ineffective against it.

Professor Charlie Gourley and Dr Robb Hollis at the Nicola Murray Centre for Ovarian Cancer Research, University of Edinburgh, lead crucial research and clinical trials for LGSOC. They are also conducting laboratory studies to inform future clinical trials.

In partnership, the Low-Grade Serous Ovarian Cancer Initiative and the University of Edinburgh Development Fund are committed to advancing LGSOC research. Your support will fund this essential work and help us achieve breakthroughs for LGSOC.

To learn more about the Low-Grade Serous Ovarian Cancer Initiative, visit www.lgsoc.org.